Rapid Micro Biosystems (RPID) Receivables - Other (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Receivables - Other of $119000.0 for Q1 2026, up 1883.33% on a YoY basis from $6000.0 in Q1 2025, and down 17.36% sequentially from $144000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Receivables - Other (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Receivables - Other data on file, last reported at $119000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Other rose 1883.33% year-over-year to $119000.0; the trailing twelve-month figure through Mar 2026 stood at $119000.0 (up 1883.33% YoY), and the FY2025 full-year result was $144000.0, up 2300.0% from the prior year.
- Receivables - Other slipped to $119000.0 in Q1 2026, from $144000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $303000.0 in Q2 2023 to a low of $6000.0 in Q4 2024.
- A 5-year average of $102647.1 and a median of $94000.0 in 2024 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other plunged 94.74% in 2022 and soared 2300.0% in 2025, its largest moves.
- Tracing RPID's Receivables - Other over 5 years: stood at $112000.0 in 2022, then slumped by 54.46% to $51000.0 in 2023, then sank by 88.24% to $6000.0 in 2024, then soared by 2300.0% to $144000.0 in 2025, then decreased by 17.36% to $119000.0 in 2026.
- Business Quant data shows RPID's Receivables - Other at $119000.0 in Q1 2026, $144000.0 in Q4 2025, and $144000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119,000.00 |
| Mar 31, 2026 | 119,000.00 |
| Dec 31, 2025 | 144,000.00 |
| Dec 31, 2025 | 144,000.00 |
| Sep 30, 2025 | 144,000.00 |
| Sep 30, 2025 | 144,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 174,000.00 |
| Sep 30, 2024 | 174,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Mar 31, 2024 | 94,000.00 |
| Mar 31, 2024 | 94,000.00 |
| Dec 31, 2023 | 51,000.00 |
| Dec 31, 2023 | 51,000.00 |